-
1دورية أكاديمية
المؤلفون: Mavropoulos, A., Orfanidou, T., Liaskos, C., Smyk, D. S., Spyrou, V., Sakkas, L. I., Rigopoulou, E. I., Bogdanos, D. P.
مصطلحات موضوعية: adalimumab, autoantibody, caspase 3, cyclophosphamide, desmoglein, etanercept, glucocorticoid, infliximab, kc 706, methotrexate, mitogen activated protein kinase p38, mitogen activated protein kinase p38 inhibitor, mycophenolic acid 2 morpholinoethyl ester, rituximab, unclassified drug, apoptosis, autoimmunity, cell adhesion, corticosteroid therapy, drug withdrawal, enzyme activation, enzyme activity, enzyme inhibition, human, immunopathogenesis, immunosuppressive treatment, inflammation, keratinocyte, mediator, multicenter study (topic)
-
2دورية أكاديمية
المؤلفون: Vasilopoulos, Y., Bagiatis, V., Stamatopoulou, D., Zisopoulos, D., Alexiou, I., Sarafidou, T., Settas, L., Sakkas, L., Mamuris, Z.
مصطلحات موضوعية: Anti-CCP, Anti-TNF, Association, Pharmacogenetics, Polymorphism, adalimumab, cyclic citrullinated peptide antibody, etanercept, infliximab, leflunomide, methotrexate, rheumatoid factor, tumor necrosis factor inhibitor, antirheumatic agent, autoantibody, biological marker, cyclic citrullinated peptide, cyclopeptide, TNFRSF1A protein, human, TNFRSF1B protein, tumor necrosis factor alpha, tumor necrosis factor receptor 1, tumor necrosis factor receptor 2, adult, aged, allele, article, cohort analysis, controlled study
-
3دورية أكاديمية
المؤلفون: Vasilopoulos, Y., Bagiatis, V., Stamatopoulou, D., Zisopoulos, D., Alexiou, I., Sarafidou, T., Settas, L., Sakkas, L., Mamuris, Z.
المصدر: Clinical and Experimental Rheumatology ; ://WOS:000295351900015
مصطلحات موضوعية: pharmacogenetics, anti-TNF, association, anti-CCP, polymorphism, TUMOR-NECROSIS-FACTOR, GENE POLYMORPHISM, FUTURE-DIRECTIONS, THERAPY, DISEASE, POSITION-308, VALIDATION, INFLIXIMAB, ANTIBODIES, Rheumatology
-
4دورية أكاديمية
المؤلفون: Barouta, G., Karapetsa, M., Kostopoulou, E., Alexiou, I., Koukoulis, G., Sakkas, L. I.
المصدر: Jcr-Journal of Clinical Rheumatology ; ://WOS:000282508500006
مصطلحات موضوعية: rheumatoid arthritis, tonsil, tuberculosis, adalimumab, TUMOR-NECROSIS-FACTOR, FACTOR ANTAGONISTS, RISK, INFECTION, TNF, LYMPHOTOXIN, INFLIXIMAB, ANTIBODY, IMMUNITY, THERAPY, Rheumatology
-
5دورية أكاديمية
المؤلفون: Alexiou, I., Germenis, A., Koutroumpas, A., Kontogianni, A., Theodoridou, K., Sakkas, L. I.
المصدر: Clinical Rheumatology ; ://WOS:000253974600015
مصطلحات موضوعية: anti-cyclic citrullinated antibodies, autoantibodies, biomarkers, extra-articular manifestations, rheumatoid arthritis, RADIOLOGICAL PROGRESSION, DIAGNOSTIC-VALUE, ANTIBODIES, DISEASE, ASSOCIATION, INFLIXIMAB, Rheumatology
-
6
المؤلفون: Daoussis D., Konstantopoulou G., Kraniotis P., Sakkas L., Liossis S.-N.
المصدر: Seminars in Arthritis and Rheumatism ; https://www.scopus.com/inward/record.uri?eid=2-s2.0-85047192201&doi=10.1016%2fj.semarthrit.2018.04.003&partnerID=40&md5=cde7820a1c435b2a747c832ada9f1758Test
مصطلحات موضوعية: adalimumab, biological product, certolizumab pegol, infliximab, methotrexate, secukinumab, tocilizumab, tumor necrosis factor inhibitor, ustekinumab, immunosuppressive agent, adult, biological therapy, bone biopsy, case report, clinical article, clinical feature, disease exacerbation, drug efficacy, drug response, drug withdrawal, female, human, human tissue, liver toxicity, middle aged, pain intensity, priority journal, Review, SAPHO syndrome, skin defect